30,265 Shares in Phreesia, Inc. $PHR Purchased by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC purchased a new position in shares of Phreesia, Inc. (NYSE:PHR) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 30,265 shares of the company’s stock, valued at approximately $774,000. Cubist Systematic Strategies LLC owned approximately 0.05% of Phreesia as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Arcadia Investment Management Corp MI raised its holdings in Phreesia by 0.7% during the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company’s stock worth $2,371,000 after purchasing an additional 615 shares in the last quarter. QRG Capital Management Inc. raised its holdings in Phreesia by 8.0% during the first quarter. QRG Capital Management Inc. now owns 11,118 shares of the company’s stock worth $284,000 after purchasing an additional 827 shares in the last quarter. Hsbc Holdings PLC raised its holdings in Phreesia by 9.0% during the first quarter. Hsbc Holdings PLC now owns 14,241 shares of the company’s stock worth $356,000 after purchasing an additional 1,177 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Phreesia by 53.0% during the first quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock worth $137,000 after purchasing an additional 1,825 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Phreesia by 1.0% during the first quarter. Bank of New York Mellon Corp now owns 197,315 shares of the company’s stock worth $5,043,000 after purchasing an additional 2,048 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Evan Roberts sold 3,400 shares of the firm’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $32.46, for a total transaction of $110,364.00. Following the sale, the insider owned 724,368 shares in the company, valued at approximately $23,512,985.28. This trade represents a 0.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Lisa Egbuonu-Davis sold 2,802 shares of the firm’s stock in a transaction that occurred on Thursday, June 26th. The stock was sold at an average price of $27.67, for a total transaction of $77,531.34. Following the sale, the director owned 22,037 shares in the company, valued at approximately $609,763.79. This trade represents a 11.28% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 109,292 shares of company stock valued at $3,295,323 in the last 90 days. Insiders own 5.50% of the company’s stock.

Wall Street Analysts Forecast Growth

PHR has been the subject of several analyst reports. KeyCorp increased their price target on shares of Phreesia from $28.00 to $35.00 and gave the stock an “overweight” rating in a report on Monday, July 14th. JMP Securities increased their target price on shares of Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a report on Monday. Canaccord Genuity Group increased their target price on shares of Phreesia from $34.00 to $38.00 and gave the company a “buy” rating in a report on Friday, September 5th. Wall Street Zen raised shares of Phreesia from a “hold” rating to a “buy” rating in a report on Sunday, June 1st. Finally, DA Davidson raised shares of Phreesia to a “strong-buy” rating in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the company. According to MarketBeat, Phreesia presently has an average rating of “Buy” and a consensus price target of $34.08.

Phreesia Stock Down 1.0%

PHR stock opened at $26.51 on Wednesday. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $32.76. The company’s 50 day simple moving average is $28.27 and its 200-day simple moving average is $26.50. The firm has a market capitalization of $1.58 billion, a PE ratio of -63.12 and a beta of 0.72. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95.

Phreesia (NYSE:PHR) last announced its earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.08. Phreesia had a negative net margin of 5.35% and a negative return on equity of 9.00%. The firm had revenue of $117.26 million for the quarter, compared to analyst estimates of $116.39 million. During the same quarter last year, the business earned ($0.03) earnings per share. Phreesia’s revenue was up 14.9% compared to the same quarter last year. Phreesia has set its FY 2026 guidance at EPS. Equities analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.